E2F4 and E2F1 have similar proliferative properties but different apoptotic and oncogenic properties in vivo

Molecular and Cellular Biology

Volumn 20, Issue 10, 2000, Pages 3417-3424

  Wang, Dawei ^a   Russell, Jamie L ^a   Johnson, David G ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR E2F;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL CULTURE; CELL PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINOBLASTOMA;

ANIMALS; APOPTOSIS; CARRIER PROTEINS; CELL CYCLE PROTEINS; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN E; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; E2F4 TRANSCRIPTION FACTOR; EPIDERMIS; KERATINOCYTES; MICE; MICE, TRANSGENIC; PROTEINS; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P14ARF;

EID: 0034012005     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.10.3417-3424.2000     Document Type: Article

References (37)

1. ARF links the tumour suppressors RB and p53. Nature 395:124-125. (Letter.)
2. Beijersbergen, R. L., R. M. Kerkhoven, L. Zhu, L. Carlee, P. M. Voorhoeve, and R. Bernards. 1994. E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo. Genes Dev. 8:2680-2690.
3. DeGregori, J., G. Leone, A. Miron, L. Jakoi, and J. R. Nevins. 1997. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc. Natl. Acad. Sci. USA 94:7245-7250.
4. Dover, R., and N. A. Wright. 1991. The cell proliferation kinetics of the epidermis, p. 239-265. In L. A. Goldsworth (ed.), Physiology, biochemistry, and molecular biology of the skin, vol. 1. Oxford University Press, New York, N.Y.
5. Dynlacht, B. D., K. Moberg, J. A. Lees, E. Harlow, and L. Zhu. 1997. Specific regulation of E2F family members by cyclin-dependent kinases. Mol. Cell. Biol. 17:3867-3875.
6. Dyson, N. 1998. The regulation of E2F by pRB-family proteins. Genes Dev. 12:2245-2262.
7. Ginsberg, D., G. Vairo, T. Chittenden, Z. X. Xiao, G. Xu, K. L. Wydner, J. A. DeCaprio, J. B. Lawrence, and D. M. Livingston. 1994. E2F-4, a new member of the E2F transcription factor family, interacts with p107. Genes Dev. 8:2665-2679.
8. Ikeda, M., H. Orimo, H. Moriyama, E. Nakajima, N. Matsubara, R. Mibu, N. Tanaka, T. Shimada, A. Kimura, and K. Shimizu. 1998. Close correlation between mutations of E2F4 and hMSH3 genes in colorectal cancers with microsatellite instability. Cancer Res. 58:594-598.
9. Ikeda, M. A., L. Jakoi, and J. R. Nevins. 1996. A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation. Proc. Natl. Acad. Sci. USA 93:3215-3220.
10. Johnson, D. G. 1995. Regulation of E2F-1 gene expression by p 130(Rb2) and D-type cyclin kinase activity. Oncogene 11:1685-1692.
11. Johnson, D. G., W. D. Cress, L. Jakoi, and J. R. Nevins. 1994. Oncogenic capacity of the E2F1 gene. Proc. Natl. Acad. Sci. USA 91:12823-12827.
12. Lindeman, G. J., S. Gaubatz, D. M. Livingston, and U. Ginsberg. 1997. The subcellular localization of E2F-4 is cell-cycle dependent. Proc. Natl. Acad. Sci. USA 94:5095-5100.
13. Lukas, J., B. O. Petersen, K. Holm, J. Bartek, and K. Helin. 1996. Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression. Mol. Cell. Biol. 16:1047-1057.
14. Magae, J., C. L. Wu, S. Illenye, E. Harlow, and N. H. Heintz. 1996. Nuclear localization of DP and E2F transcription factors by heterodimeric partners and retinoblastoma protein family members. J. Cell Sci. 109:1717-1726.
15. Moberg, K., M. A. Starz, and J. A. Lees. 1996. E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry. Mol. Cell. Biol. 16:1436-1449.
16. Morkel, M., J. Wenkel, A. J. Bannister, T. Kouzaridesand, and C. Hagemeier. 1997. An E2F-like repressor of transcription. Nature 390:567-568.
17. Muller, H., M. C. Moroni, E. Vigo, B. O. Petersen, J. Bartek, and K. Helin. 1997. Induction of S-phase entry by E2F transcription factors depends on their nuclear localization. Mol. Cell. Biol. 17:5508-5520.
18. Nevins, J. R. 1998. Toward an understanding of the functional complexity of the E2F and retinoblastoma families. Cell Growth Differ. 9:585-593.
19. Pierce, A. M., S. M. Fischer, C. J. Conti, and D. G. Johnson. 1998. Deregulated expression of E2F1 induces hyperplasia and cooperates with ras in skin tumor development. Oncogene 16:1267-1276.
20. Pierce, A. M., I. B. Gimenez-Conti, R. Schneider-Broussard, L. A. Martinez, C. J. Conti, and D. G. Johnson. 1998. Increased E2F1 activity induces skin tumors in mice heterozygous and nullizygous for p53. Proc. Natl. Acad. Sci. USA 95:8858-8863.
21. Pierce, A. M., R. Schneider-Broussard, I. B. Gimenez-Conti, J. L. Russell, C. J. Conti, and D. J. Johnson. 1999. E2F1 has both oncogenic and tumor-suppressive properties in a transgenic model. Mol. Cell. Biol. 19:6408-6414.
22. Pierce, A. M., R. Schneider-Broussard, J. L. Philhower, and D. G. Johnson. 1998. Differential activities of E2F family members suggest unique functions in regulating transcription. Mol. Carcinog. 22:190-198.
23. Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 92:713-723.
24. Quelle, D. E., F. Zindy, R. A. Ashman, and C. J. Sherr. 1995. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83:993-1000.
25. Quintanilla, M., K. Brown, M. Ramsden, and A. Balmain. 1986. Carcinogen specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature 322:78-80.
26. Ramirez, A., A. Bravo, J. L. Jorcano, and M. Vida. 1994. Sequences 5′ of the bovine keratin 5 gene direct tissue-and-cell-type-specific expression of a lacZ gene in the adult and during development. Differentiation 58:53-64.
27. Rodriquez-Puebla, M. L., M. LaCava, I. B. Gimenez-Conti, D. J. Johnson, and C. J. Conti. 1998. Deregulated expression of cell-cycle proteins during premalignant progression in SENCAR mouse skin. Oncogene 17:2251-2258.
28. Sardet, C., M. Vidal, D. Cobrinik, Y. Geng, C. Onufryk, A. Chen, and R. A. Weinberg. 1995. E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. Proc. Natl. Acad. Sci. USA 92:2403-2407.
29. Sellers, W. R., J. W. Rodgers, W. G. Kaelin, and D. M. Livinston. 1995. A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites. Proc. Natl. Acad. Sci. USA 92:11544-11548.
30. Sherr, C. J. 1996. Cancer cell cycles. Science 274:1672-1677.
31. Sherr, C. J. 1998. Tumor surveillance via the ARF-p53 pathway. Genes Dev. 12:2984-2991.
32. Trimarchi, J. M., B. Fairchild, R. Verona, K. Moberg, N. Andon, and J. A. Lees. 1998. E2F-6, a member of the E2F family that can behave as a transcriptional repressor. Proc. Natl. Acad. Sci. USA 95:2850-2855.
33. Verona, R., K. Moberg, S. Estes, M. Starz, J. P. Vernon, and J. A. Lees. 1997. E2F activity is regulated by cell cycle-dependent changes in subcellular localization. Mol. Cell. Biol. 17:7268-7282.
34. Weber, J. D., L. J. Taylor, M. F. Roussel, C. J. Sherr, and D. Bar-Sagi. 1999. Nucleolar Arf sequesters Mdm2 and activates p53. Nat. Cell Biol. 1:20-26.
35. Weintraub, S. J., K. N. Chow, R. X. Luo, S. H. Zhang, S. He, and D. C. Dean. 1995. Mechanism of active transcriptional repression by the retinoblastoma protein. Nature 375:812-815.
36. Xu, G., D. M. Livingston, and W. Krek. 1995. Multiple memhers of the E2F transcription factor family are the products of oncogenes. Proc. Natl. Acad. Sci. USA 92:1357-1361.
37. Zhang, Y., and Y. Xiong. 1999. Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53. Mol. Cell 3:579-591.